Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Experimental Hematology|August 1, 1989
Comparison of in vitro inhibition of etoposide (VP16) on leukemic and normal myeloid, erythroid clonogenic cellsL Lagneaux, J P Marie, A Delforge, et al.
Annals of the New York Academy of Sciences|January 1, 1985
Lactoferrin: its role as a regulator of human granulopoiesis?A Delforge, P Stryckmans, J P Prieels, et al.
Journal of Hematotherapy|April 1, 1997
Ex vivo expansion of CD34 + CD38- cord blood cellsC De Bruyn, A Delforge, D Bron, et al.
Bone Marrow Transplantation|March 7, 2003
Donor lymphocyte infusions in adult haploidentical transplant: a dose finding studyP Lewalle, A Triffet, A Delforge, et al.
European Journal of Cancer & Clinical Oncology|December 1, 1987
Sensitivity of normal human bone marrow myeloid progenitor cells to anthracycline, cisplatin, anthracene and flavone acetic acid derivatives, and its relevance for the prediction of human plasma concentrations of anticancer drugsP Dodion, D Bron, M A Mattelaer, et al.
The Journal of Infectious Diseases|November 1, 1996
Imbalance in production of cytokines by bone marrow stromal cells following cytomegalovirus infectionL Lagneaux, A Delforge, R Snoeck, et al.
Stem Cells (Dayton, Ohio)|May 1, 1995
Comparison of the coexpression of CD38, CD33 and HLA-DR antigens on CD34+ purified cells from human cord blood and bone marrowC De Bruyn, A Delforge, D Bron, et al.
Presse Medicale (Paris, France : 1983)|June 10, 1989
[Adoptive immunotherapy with interleukin 2. Initial results of a pilot study in 6 cancer patients]J P Sculier, D Bron, A Delforge, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 1, 1990
Inhibitory effects of potent inhibitors of human immunodeficiency virus and cytomegalovirus on the growth of human granulocyte-macrophage progenitor cells in vitroR Snoeck, L Lagneaux, A Delforge, et al.
Blood|December 1, 1990
Analysis of interferon-inducible genes in cells of chronic myeloid leukemia patients responsive or resistant to an interferon-alpha treatmentI M Clauss, B Vandenplas, M G Wathelet, et al.
Pageof 6